Latest News

Journal Articles

Autoimmune

Could hyaluronic acid contribute to chronic white matter injury?

Can living in a sunnier climate in your youth reduce the risk of MS?

Could transcranial direct current stimulation offer relief from fatigue in multiple sclerosis sufferers?

Cerebrovascular disease

Investigational gene therapy licensed for Parkinson’s disease: industry news round-up

International Nurses Day: a day in the life of Lynn Hundley

International Nurses Day: a day in the life of Ismalia de Sousa

CNS/PNS/SNS

Spinal cord injuries could be repaired by stem cell-based therapy

Can myelin stimulate neuron growth in spinal cord injuries?

Reprogrammed neuronal stem cells survive long-term in spinal cord injury model

Cognitive/neurodegenerative disorders

Investigational therapy for ALS now in clinical trials

FENS 2018: Epigenetic target identified in early treatment of Alzheimer’s disease

FENS 2018: CRISPR–Cas gene editing could treat Huntington’s disease

Demyelinating disease

FENS 2018: Novel treatments for multiple sclerosis on the horizon

Ocrelizumab rejected for primary progressive multiple sclerosis by NICE

Ask the Experts: Emerging therapies in multiple sclerosis (Part II: stem cells and future research)

Development and pediatrics

Autism risk may be linked to mother’s microbiome health

FENS 2018: Stem cells and brain organoids – the ‘hot spots’ of brain research

Genes associated with infantile forms of schizophrenia identified

Epilepsy and seizure

First FDA-approved cannabinoid-derived drug for seizures

Epilepsy and cannabinoids: current consensus, controversies and future outlook

Reports of brain damage call a halt to Bellicum trials: industry news round-up

Genetics

Personalized neurological fingerprint could increase effectiveness of Alzheimer’s treatment

FENS 2018: Stem cells and brain organoids – the ‘hot spots’ of brain research

FENS 2018: Genetic variations in psychiatric disorders may affect response to treatment

Headache

Aimovig® receives positive CHMP opinion for the prevention of migraine

Aimovig® gains US FDA approval for the preventive treatment of migraine

ALKS 5461 accepted for review following previous refusal-to-file for depression: industry news round-up

Immune disorders and inflammation

FENS 2018: Immune system offers new way of treating Alzheimer’s disease

FENS 2018: Could anxiety and inflammation be treated with cannabis?

Could hyaluronic acid contribute to chronic white matter injury?

Infection

Do viruses play a role in Alzheimer’s disease?

NCTalks at SfN17: Kijun Yoon gives a Zika update

SfN17: CRISPR and iPSCs – new techniques to study the brain

Injury/trauma

Athletes with ADHD may be at greater risk following concussion

Heading a soccer ball could leave lasting damage

FENS 2018: Epigenetics – trans-generational effects of traumatic experiences

Movement disorders

BrainStorm scraps initial access to NurOwn® for amyotrophic lateral sclerosis

Parkinson’s drugs may cause impulse control disorders

Is there a link between diabetes and Parkinson’s disease?

Neuro-ophthalmology

Vision in Alzheimer's disease: a focus on the anterior afferent pathway

Glaucoma research gives a glimpse of a novel neuroprotection mechanism

Management of glaucoma as a neurodegenerative disease

Neurometabolic

Epigenetics, opioids and immune regulation: interviews from SfN17

Jeffrey Iliff: glymphatics, Alzheimer’s and future directions

SfN17: Neurodegeneration and the microbiome – new research highlights

Neuromuscular

New genetic suspects identified for ALS and FTD

Novel discovery in motor neuron disease may pave the way for future treatments

EAN 2017: Guillain-Barré syndrome risk associated with month of birth

Neuropsychiatry

Autism risk may be linked to mother’s microbiome health

Athletes with ADHD may be at greater risk following concussion

FENS 2018: Genetic variations in psychiatric disorders may affect response to treatment

Oncology/tumor

Brain metastases could be tackled using new therapy with silibinin

World Brain Tumor Day: cancer prevention advice and common perceptions

DCVax®-L as a potential vaccine against glioblastoma

Pain

NCTalks with Irene Tracey: lessons from pain, analgesia and anesthesia

Aimovig® gains US FDA approval for the preventive treatment of migraine

Effects of gabapentin, pregabalin and gastroretentive gabapentin on simulated driving, daytime sedation and cognition

Sleep

#NCIntroduces... Sleep science

Better sleep works like a dream at reducing fear learning

Sleep research realizes the dream of understanding brain plasticity mechanisms